Synthesis of a Hexacyclic Acridinium Cyanine Dye
FULL PAPER
(Sigma) and 10% fetal bovine serum (Sigma). The cells were maintained
at 378C in a humidified 5% CO2 atmosphere. For the imaging experi-
ments, the cells were seeded at 104 cells per well in 0.2 mL of culture
medium in untreated 8-well coverglass chambers (Lab-TekTM, Nunc) and
allowed to grow to confluence for 24 h. The culture media was replaced
with the medium containing the dye and incubated for 5–25 min. Follow-
ing incubation, the chambers were washed twice with PBS and images
were collected at 208C.
logue 3, which is blocked into a twisted conformation and
non-fluorescent, compound 9 exhibits a high molar absorp-
tivity and remarkable fluorescence properties: a fluores-
cence quantum yield approaching unity in organic solvents
and remaining above 0.5 in water. While it exists mainly in
its monomeric form in organic solvents, dye 9 forms aggre-
gates in water or in binary aqueous-based mixtures. Interest-
ingly, these aggregates are characterised by a longer fluores-
cence lifetime (33 vs. 7 ns) but weaker fluorescence intensity
than those of the monomeric dye. The aggregation process
is both time and concentration dependent, but can, however,
be reversed by addition of DNA, thus, resulting in a twofold
increase in fluorescence. As anticipated considering its struc-
tural similarity with the well-known quadruplex binding
ligand RHPS4, dye 9 also recognises these alternative DNA
secondary structures, and studies aiming at designing quad-
ruplex-specific analogues based on this scaffold are currently
underway in our group. Taken altogether, the unique bright-
ness and DNA-binding properties of this hexacyclic mole-
cule make it perfectly suited for in vivo DNA sensing or
staining applications. This was confirmed by preliminary
studies demonstrating its fast and efficient cellular uptake.
Finally, the observed cytotoxicity of dye 9 on a line of
human breast cancer cells suggests that molecules based on
this hexacyclic scaffold and belonging to the family of acri-
dines (pharmacophores with potent antibacterial and/or an-
titumor activities)[6] could also find valuable applications as
anti-cancer agents.
General experimental procedures: Solvents were of HPLC or reagent
quality and purchased commercially. Starting materials were purchased
commercially and used without further purification. Compounds were
characterised by using 1H and 13C NMR spectroscopy. The spectra were
recorded on
a Bruker Avance DRX 400 spectrometer at 400 and
100.6 MHz, respectively. Chemical shifts are reported as d values (ppm)
with reference to the residual solvent peaks.
Acridinium monomethine cyanine dye (3): Phosphoryl chloride (130 mL,
1.39 mmol) was added dropwise to a solution of 1,2,4-triazole (0.320 g,
4.62 mmol) in dry acetonitrile (8 mL) at 08C (ice bath). Then, triethyla-
mine (0.775 mL, 5.55 mmol) was added and the mixture was stirred for
30 min. A solution of 10-methyl-9ACTHNUTRGNE(UNG 10H)-acridone (100 mg, 0.48 mmol) in
CH2Cl2 (5 mL) was added to the phosphoryl tristriazolide and the mix-
ture was refluxed for 48 h. A solution of freshly prepared 1,2,3-trimethyl-
benzimidazolium iodide[13] (150 mg, 0.5 mmol) in CH2Cl2 (5 mL) and trie-
thylamine (1 mL) was added to the above mixture and stirring was con-
tinued for further 48 h at 608C before the solvents were removed under
reduced pressure. The residue was then dissolved in CH2Cl2, washed with
water (100 mL), dried over magnesium sulphate and purified by flash
column chromatography (CH2Cl2/MeOH 98:2). The desired compound 3
was obtained pure as a dark-brown amorphous solid (14 mg, 4% yield).
1H NMR (CD3OD): d=8.29 (1H, d, J=8 Hz; ArH), 7.88–7.84 (2H, m;
ArH), 7.71–7.65 (3H, m; ArH), 7.60–7.59 (2H, m; ArH), 7.55 (1H, d, J=
8 Hz; ArH), 6.91–6.86 (2H, m; ArH), 6.70 (1H, s; CH), 3.83 (3H, s;
CH3), 3.34 ppm (6H, s; CH3); 13C NMR (CD3OD): d=151.5 (C), 147.4
(C), 141.2 (C), 139.6 (C), 132.2 (CH), 131.8 (CH), 131.2 (CH), 126.2
(CH), 125.7 (CH), 124.1 (CH), 122.1 (CH), 121.7 (C), 121.5 (CH), 118.7
(C), 114.9 (CH), 114.2 (CH), 112.1 (CH), 93.1 (CH), 33.5 (CH3),
31.4 ppm (CH3); HRMS (ESI): m/z calcd for C24H22N3: 352.181 [M]+;
found 352.179.
Experimental Section
Hexacyclic acridinium dye (9): Two to three drops of N,N-dimethylfor-
mamide were added to a solution of compound 7 (110 mg, 0.31 mmol) in
thionyl chloride (10 mL) and the reaction mixture was refluxed at 1008C
for 30 min. Solvents were then removed under reduced pressure, the un-
stable 9-choloroacridinium was dissolved in a mixture of anhydrous
CH2Cl2 (10 mL) and freshly distilled Et3N (1 mL) and the mixture was
stirred overnight at room temperature. The solvents were removed under
reduced pressure and the crude mixture was purified by flash column
chromatography (CH2Cl2, then CH2Cl2/MeOH 95:5). The residue was
then dissolved in a minimal volume of methanol and one equivalent of
sodium hexafluorophosphate was added. A bright yellow solid formed,
which was collected by filtration. Thus, the desired hexacyclic acridinium
was obtained pure as a hexafluorophosphate salt (35 mg, 24% yield).
1H NMR (CD3OD): d=8.14 (1H, d, J=8 Hz; ArH), 7.96 (1H, d, J=
8 Hz; ArH), 7.69–7.62 (2H, m; ArH), 7.57–7.52 (2H, m; ArH), 7.38 (1H,
t, J=8 Hz; ArH), 7.33 (1H, t, J=8 Hz; ArH), 7.15–7.11(2H, m; ArH),
7.04–6.97 ppm (2H, m; ArH); 13C NMR (CD3OD): d=143.8 (C), 140.9
(C), 139.9 (C), 139.2 (C), 133.9 (C), 133.9 (CH), 133.8 (CH), 133.0 (C),
127.3 (CH), 127.2 (C), 124.9 (CH), 124.7 (CH), 122.7 (CH), 116.2 (C),
115.3 (CH), 115.0 (CH), 112.2 (C), 110.9 (CH), 108.8 (CH), 105.6 (CH),
87.4 (CH), 33.6 (CH3), 29.2 ppm (CH3); HRMS (ESI): m/z calcd for
C23H18N3: 336.150 [M]+, found 336.148.
Spectroscopy: The photophysical studies were carried out in dimethyl
sulfoxide (DMSO), methanol (MeOH), glycerol (Gly) and H2O (all of
spectrofluorimetric grade). The samples were prepared by dilution of a
stock solution of dye 9 (c=5 mm in DMSO). Absorption spectra were re-
corded with an Agilent 8453 Diode Array Spectrophotometer. Molar ab-
sorption values (e) were calculated by applying the Lambert–Beer law to
the absorbance spectra (Amax <1.5) of the compounds.
Steady-state photoluminescence spectra were measured in right angle
mode with a HORIBA FluoroMaxꢃ-4. The concentration of the air-equi-
librated sample solutions was adjusted to obtain absorption values A<
0.1 at the excitation wavelength. Emission quantum yields were deter-
mined according to the approach described by Demas and Crosby[24] by
using fluorescein (Ff =0.95[17]) as standard. Ten and two millimeter path
length square optical Suprasil Quartz (QS) cuvettes were used for meas-
urements at room temperature of dilute and concentrated solutions, re-
spectively.
Fluorescence lifetimes were measured with HORIBA Jobin Yvon IBH
5000F time-correlated single-photon counting device by using pulsed
NanoLED excitation sources at l=404 and 467 nm. Analysis of the lumi-
nescence decay profiles against time was accomplished with the Decay
Analysis Software DAS6 provided by the manufacturer.
Fluorescence microscopy: Imaging was performed by using a confocal
laser scanning microscope (Leica TCS SP5), coupled to a CW argon-ion
laser (l=488 nm). The fluorescence emission of the dye in the cells was
spectrally dispersed by using a prism and detected by using a photomulti-
plier tube. Water immersion 63ꢂ objectives (NA=1.23) were used to
image. The human breast carcinoma cells (MD 231, ECACC) were
grown in Dulbeccoꢁs modified Eagleꢁs medium (DMEM, Gibco), supple-
mented with 100 UmLÀ1 penicillin (Sigma), 100 mgmLÀ1 streptomycin
Acknowledgements
The authors thank the Welcome Trust and EPSRC for funding, including
the EPSRC Career Acceleration Fellowship to MKK (U.K.).
Chem. Eur. J. 2012, 00, 0 – 0
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
7
&
ÞÞ
These are not the final page numbers!